Extrait

This is a prospective phase II trial of docetaxel-samarium in patients with hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine.

Critère d'inclusion

• Prostate cancer

Liens

• ictrp
• nct